Research output per year
Research output per year
- 13 results
Search results
-
2024
Dendritic cell subsets and implications for cancer immunotherapy
Chen, M. Y., Zhang, F., Goedegebuure, S. P. & Gillanders, W. E., 2024, In: Frontiers in immunology. 15, 1393451.Research output: Contribution to journal › Review article › peer-review
Open Access12 Scopus citations -
2021
Challenges targeting cancer neoantigens in 2021: a systematic literature review
Chen, I., Chen, M. Y., Goedegebuure, S. P. & Gillanders, W. E., 2021, In: Expert Review of Vaccines. 20, 7, p. 827-837 11 p.Research output: Contribution to journal › Review article › peer-review
Open Access22 Scopus citations -
Tumor-on-chip modeling of organ-specific cancer and metastasis
Del Piccolo, N., Shirure, V. S., Bi, Y., Goedegebuure, S. P., Gholami, S., Hughes, C. C. W., Fields, R. C. & George, S. C., Aug 2021, In: Advanced Drug Delivery Reviews. 175, 113798.Research output: Contribution to journal › Review article › peer-review
Open Access81 Scopus citations -
Understanding and addressing barriers to successful adenovirus-based virotherapy for ovarian cancer
Gonzalez-Pastor, R., Goedegebuure, P. S. & Curiel, D. T., May 2021, In: Cancer gene therapy. 28, 5, p. 375-389 15 p.Research output: Contribution to journal › Review article › peer-review
Open Access14 Scopus citations -
2020
The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution
Human Tumor Atlas Network, Apr 16 2020, In: Cell. 181, 2, p. 236-249 14 p.Research output: Contribution to journal › Review article › peer-review
Open Access341 Scopus citations -
Tumor-on-a-chip platform to interrogate the role of macrophages in tumor progression
Bi, Y., Shirure, V. S., Liu, R., Cunningham, C., Ding, L., Meacham, J. M., Goedegebuure, S. P., George, S. C. & Fields, R. C., Sep 1 2020, In: Integrative Biology. 12, 9, p. 221-232 12 p.Research output: Contribution to journal › Review article › peer-review
Open Access53 Scopus citations -
2017
Preclinical and clinical development of neoantigen vaccines
Li, L., Goedegebuure, S. P. & Gillanders, W. E., Dec 1 2017, In: Annals of Oncology. 28, p. xii11-xii17Research output: Contribution to journal › Review article › peer-review
Open Access182 Scopus citations -
2015
Developing a clinical development paradigm for translation of a mammaglobin-A DNA vaccine
Li, L., Goedegebuure, S. P., Fleming, T. P. & Gillanders, W. E., Jul 1 2015, In: Immunotherapy. 7, 7, p. 709-711 3 p.Research output: Contribution to journal › Review article › peer-review
2 Scopus citations -
2011
Cancer genome sequencing and its implications for personalized cancer vaccines
Li, L., Goedegebuure, P., Mardis, E. R., Ellis, M. J. C., Zhang, X., Herndon, J. M., Fleming, T. P., Carreno, B. M., Hansen, T. H. & Gillanders, W. E., Dec 2011, In: Cancers. 3, 4, p. 4191-4211 21 p.Research output: Contribution to journal › Review article › peer-review
Open Access25 Scopus citations -
Potential targets for pancreatic cancer immunotherapeutics
Dodson, L. F., Hawkins, W. G. & Goedegebuure, P., Apr 2011, In: Immunotherapy. 3, 4, p. 517-537 21 p.Research output: Contribution to journal › Review article › peer-review
Open Access58 Scopus citations -
2005
CD25+CD4+ regulatory t-cells in cancer
Linehan, D. C. & Goedegebuure, P. S., 2005, In: Immunologic Research. 32, 1-3, p. 155-168 14 p.Research output: Contribution to journal › Review article › peer-review
109 Scopus citations -
2004
Mammaglobin-based strategies for treatment of breast cancer
Goedegebuure, P. S., Watson, M. A., Viehl, G. T. & Fleming, T. P., Sep 2004, In: Current Cancer Drug Targets. 4, 6, p. 531-542 12 p.Research output: Contribution to journal › Review article › peer-review
33 Scopus citations -
1997
Zytotoxische T-Lymphozyten und die Erkennung von Tumorantigenen - Ein Weg zur 'Tumorschutzimpfung?
Translated title of the contribution :Cytotoxic T-lymphocytes and the recognition of tumor antigens. An approach to anti-tumor vaccines? Research output: Contribution to journal › Review article › peer-review